Category list : Antiviral agents
Sort by: Newest first Oldest first A-Z Z-A
-
Hepatitis C: tackling the silent killer Subscription
About 200,000 people are living with hepatitis C in the UK, but it is estimated that around half of these remain undiagnosed. Identifying those at risk, offering tests and connecting those infected with treatment are crucial to tackling the disease.
-
HIV patients should have flu jab despite warnings, pharmacy group urges
HIV pharmacy specialists have warned that some HIV patients could be being mistakenly told that they should not take antiretrovirals at the same time as receiving the seasonal flu vaccination.
-
Naturally occurring peptides show antiviral potential against common cold Subscription
Cathelicidins could be a new therapeutic strategy for the management of human rhinovirus infection, researchers suggest.
-
An update on the management of chronic hepatitis B and C infection Subscription
Chronic hepatitis B and C infection are leading causes of liver-related morbidity and mortality worldwide. Current therapies for chronic hepatitis B virus (HBV) infection consisting of nucleos(t)ide analogues (NA) rarely lead to functional cure. With a better understanding of the HBV lifecycle, novel agents have been developed with the hope of achieving functional cure. The development of direct-acting antivirals (DAAs) for hepatitis C virus (HCV) therapy has led to ...
-
World Health Organization looks to eliminate threat of hepatitis B and C Subscription
The World Health Organization’s Marc Bulterys on the agency’s efforts to eliminate viral hepatitis by scaling up screening and improving access to new and effective drugs
-
Direct-acting antivirals successfully treating hepatitis C, says Public Health England
Public Health England is urging the public to get tested for hepatitis C after its latest figures revealed a fall in deaths from the disease, which it attributed to the introduction of direct-acting antiviral therapy.
-
No antivirals for flu until further notice, Department of Health says
Department of Health announces halt to prescribing and supplying antivirals to treat influenza as data show that circulation of the virus has returned to baseline levels.
-
Combination treatment for hepatitis C approved by FDA
The US Food and Drug Administration (FDA) has approved the use of the combination treatment Vosevi (sofosbuvir, velpatasvir and voxilaprevir) for the treatment of adults with chronic hepatitis C virus (HCV) genotypes 1–6 without cirrhosis or with mild cirrhosis.
-
Antiviral treatment improves outcomes in patients with advanced cirrhosis Subscription
Hepatitis C drug shown to reduce the need for transplant and lower mortality rate in patients with advanced liver disease.
-
Study finds no evidence for clinical effect of direct-acting antivirals against hepatitis C
Direct-acting antivirals for chronic hepatitis C, do not seem to reduce the risk of hepatitis C-related morbidity or all-cause mortality, according to a study carried out by the Cochrane Hepato-Biliary Group.
